2024-04-012025-03-312025-03-31false13706923AZIZ GULAMHUSEIN UROLOGY LTD2025-12-15falseiso4217:GBPxbrli:pure137069232024-03-31137069232025-03-31137069232024-04-012025-03-31137069232023-03-31137069232024-03-31137069232023-04-012024-03-3113706923bus:SmallEntities2024-04-012025-03-3113706923bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3113706923bus:FullAccounts2024-04-012025-03-3113706923bus:PrivateLimitedCompanyLtd2024-04-012025-03-3113706923core:WithinOneYear2025-03-3113706923core:AfterOneYear2025-03-3113706923core:WithinOneYear2024-03-3113706923core:AfterOneYear2024-03-3113706923core:ShareCapital2025-03-3113706923core:SharePremium2025-03-3113706923core:RevaluationReserve2025-03-3113706923core:OtherReservesSubtotal2025-03-3113706923core:RetainedEarningsAccumulatedLosses2025-03-3113706923core:ShareCapital2024-03-3113706923core:SharePremium2024-03-3113706923core:RevaluationReserve2024-03-3113706923core:OtherReservesSubtotal2024-03-3113706923core:RetainedEarningsAccumulatedLosses2024-03-3113706923core:LandBuildings2025-03-3113706923core:PlantMachinery2025-03-3113706923core:Vehicles2025-03-3113706923core:FurnitureFittings2025-03-3113706923core:OfficeEquipment2025-03-3113706923core:NetGoodwill2025-03-3113706923core:IntangibleAssetsOtherThanGoodwill2025-03-3113706923core:ListedExchangeTraded2025-03-3113706923core:UnlistedNon-exchangeTraded2025-03-3113706923core:LandBuildings2024-03-3113706923core:PlantMachinery2024-03-3113706923core:Vehicles2024-03-3113706923core:FurnitureFittings2024-03-3113706923core:OfficeEquipment2024-03-3113706923core:NetGoodwill2024-03-3113706923core:IntangibleAssetsOtherThanGoodwill2024-03-3113706923core:ListedExchangeTraded2024-03-3113706923core:UnlistedNon-exchangeTraded2024-03-3113706923core:LandBuildings2024-04-012025-03-3113706923core:PlantMachinery2024-04-012025-03-3113706923core:Vehicles2024-04-012025-03-3113706923core:FurnitureFittings2024-04-012025-03-3113706923core:OfficeEquipment2024-04-012025-03-3113706923core:NetGoodwill2024-04-012025-03-3113706923core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3113706923core:ListedExchangeTraded2024-04-012025-03-3113706923core:UnlistedNon-exchangeTraded2024-04-012025-03-3113706923core:MoreThanFiveYears2024-04-012025-03-3113706923core:Non-currentFinancialInstruments2025-03-3113706923core:Non-currentFinancialInstruments2024-03-3113706923dpl:CostSales2024-04-012025-03-3113706923dpl:DistributionCosts2024-04-012025-03-3113706923core:LandBuildings2024-04-012025-03-3113706923core:PlantMachinery2024-04-012025-03-3113706923core:Vehicles2024-04-012025-03-3113706923core:FurnitureFittings2024-04-012025-03-3113706923core:OfficeEquipment2024-04-012025-03-3113706923dpl:AdministrativeExpenses2024-04-012025-03-3113706923core:NetGoodwill2024-04-012025-03-3113706923core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3113706923dpl:GroupUndertakings2024-04-012025-03-3113706923dpl:ParticipatingInterests2024-04-012025-03-3113706923dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3113706923core:ListedExchangeTraded2024-04-012025-03-3113706923dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3113706923core:UnlistedNon-exchangeTraded2024-04-012025-03-3113706923dpl:CostSales2023-04-012024-03-3113706923dpl:DistributionCosts2023-04-012024-03-3113706923core:LandBuildings2023-04-012024-03-3113706923core:PlantMachinery2023-04-012024-03-3113706923core:Vehicles2023-04-012024-03-3113706923core:FurnitureFittings2023-04-012024-03-3113706923core:OfficeEquipment2023-04-012024-03-3113706923dpl:AdministrativeExpenses2023-04-012024-03-3113706923core:NetGoodwill2023-04-012024-03-3113706923core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3113706923dpl:GroupUndertakings2023-04-012024-03-3113706923dpl:ParticipatingInterests2023-04-012024-03-3113706923dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3113706923core:ListedExchangeTraded2023-04-012024-03-3113706923dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3113706923core:UnlistedNon-exchangeTraded2023-04-012024-03-3113706923core:NetGoodwill2025-03-3113706923core:IntangibleAssetsOtherThanGoodwill2025-03-3113706923core:LandBuildings2025-03-3113706923core:PlantMachinery2025-03-3113706923core:Vehicles2025-03-3113706923core:FurnitureFittings2025-03-3113706923core:OfficeEquipment2025-03-3113706923core:AfterOneYear2025-03-3113706923core:WithinOneYear2025-03-3113706923core:ListedExchangeTraded2025-03-3113706923core:UnlistedNon-exchangeTraded2025-03-3113706923core:ShareCapital2025-03-3113706923core:SharePremium2025-03-3113706923core:RevaluationReserve2025-03-3113706923core:OtherReservesSubtotal2025-03-3113706923core:RetainedEarningsAccumulatedLosses2025-03-3113706923core:NetGoodwill2024-03-3113706923core:IntangibleAssetsOtherThanGoodwill2024-03-3113706923core:LandBuildings2024-03-3113706923core:PlantMachinery2024-03-3113706923core:Vehicles2024-03-3113706923core:FurnitureFittings2024-03-3113706923core:OfficeEquipment2024-03-3113706923core:AfterOneYear2024-03-3113706923core:WithinOneYear2024-03-3113706923core:ListedExchangeTraded2024-03-3113706923core:UnlistedNon-exchangeTraded2024-03-3113706923core:ShareCapital2024-03-3113706923core:SharePremium2024-03-3113706923core:RevaluationReserve2024-03-3113706923core:OtherReservesSubtotal2024-03-3113706923core:RetainedEarningsAccumulatedLosses2024-03-3113706923core:NetGoodwill2023-03-3113706923core:IntangibleAssetsOtherThanGoodwill2023-03-3113706923core:LandBuildings2023-03-3113706923core:PlantMachinery2023-03-3113706923core:Vehicles2023-03-3113706923core:FurnitureFittings2023-03-3113706923core:OfficeEquipment2023-03-3113706923core:AfterOneYear2023-03-3113706923core:WithinOneYear2023-03-3113706923core:ListedExchangeTraded2023-03-3113706923core:UnlistedNon-exchangeTraded2023-03-3113706923core:ShareCapital2023-03-3113706923core:SharePremium2023-03-3113706923core:RevaluationReserve2023-03-3113706923core:OtherReservesSubtotal2023-03-3113706923core:RetainedEarningsAccumulatedLosses2023-03-3113706923core:AfterOneYear2024-04-012025-03-3113706923core:WithinOneYear2024-04-012025-03-3113706923core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3113706923core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3113706923core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3113706923core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3113706923core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3113706923core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3113706923core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113706923core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113706923core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113706923core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3113706923core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3113706923core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3113706923core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3113706923core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3113706923core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3113706923core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3113706923core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3113706923core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3113706923core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3113706923core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3113706923core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3113706923core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3113706923core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3113706923core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3113706923core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3113706923core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3113706923core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3113706923bus:Director12024-04-012025-03-3113706923bus:Director22024-04-012025-03-31

AZIZ GULAMHUSEIN UROLOGY LTD

Registered Number
13706923
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

AZIZ GULAMHUSEIN UROLOGY LTD
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

GULAMHUSEIN, Aziz
GULAMHUSEIN, Jenna

Registered Address

9 Earl Road
Stockport
SK4 4JS

Registered Number

13706923 (England and Wales)
AZIZ GULAMHUSEIN UROLOGY LTD
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets33,0372,671
3,0372,671
Current assets
Debtors46,5606,164
Cash at bank and on hand234,425160,590
240,985166,754
Creditors amounts falling due within one year5(28,370)(28,645)
Net current assets (liabilities)212,615138,109
Total assets less current liabilities215,652140,780
Provisions for liabilities6(577)(507)
Net assets215,075140,273
Capital and reserves
Called up share capital100100
Profit and loss account214,975140,173
Shareholders' funds215,075140,273
The financial statements were approved and authorised for issue by the Board of Directors on 15 December 2025, and are signed on its behalf by:
GULAMHUSEIN, Aziz
Director
Registered Company No. 13706923
AZIZ GULAMHUSEIN UROLOGY LTD
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Office Equipment25
2.Average number of employees

20252024
Average number of employees during the year22
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 April 243,5833,583
Additions1,1111,111
At 31 March 254,6944,694
Depreciation and impairment
At 01 April 24912912
Charge for year745745
At 31 March 251,6571,657
Net book value
At 31 March 253,0373,037
At 31 March 242,6712,671
4.Debtors: amounts due within one year

2025

2024

££
Prepayments and accrued income6,5606,164
Total6,5606,164
5.Creditors: amounts due within one year

2025

2024

££
Taxation and social security22,12121,696
Other creditors4,8935,653
Accrued liabilities and deferred income1,3561,296
Total28,37028,645
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
6.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)577507
Total577507